APA (7th ed.) Citation

JM, P., RN, J., NM, Z., JK, S., AJ, P., RR, L., . . . KJ, H. (2017). When Enough Is Enough: Decision Criteria for Moving a Known Drug into Clinical Testing for a New Indication in the Absence of Preclinical Efficacy Data. Assay and drug development technologies, 15(8), 354. https://doi.org/10.1089/adt.2017.821

Chicago Style (17th ed.) Citation

JM, Pulley, et al. "When Enough Is Enough: Decision Criteria for Moving a Known Drug into Clinical Testing for a New Indication in the Absence of Preclinical Efficacy Data." Assay and Drug Development Technologies 15, no. 8 (2017): 354. https://doi.org/10.1089/adt.2017.821.

MLA (9th ed.) Citation

JM, Pulley, et al. "When Enough Is Enough: Decision Criteria for Moving a Known Drug into Clinical Testing for a New Indication in the Absence of Preclinical Efficacy Data." Assay and Drug Development Technologies, vol. 15, no. 8, 2017, p. 354, https://doi.org/10.1089/adt.2017.821.